Group 1 - The A-share market shows a mixed performance with the Shanghai Stock Exchange Sci-Tech Innovation Board Biomedicine Index experiencing strong fluctuations [1] - The Sci-Tech Biomedicine Index ETF (588700) rose by 1.26% with a turnover rate of 4.66% and a trading volume exceeding 11 million yuan, indicating active trading [1] - The ETF closely tracks the Sci-Tech Biomedicine Index, which includes 50 large-cap companies in biomedicine, biomedical engineering, biopharmaceuticals, and other related sectors [1] Group 2 - The pharmaceutical sector has undergone a prolonged adjustment, with overall valuations at low levels and public fund holdings being underweight, suggesting potential for recovery [1] - The medical sector is highlighted as a key investment direction due to its strong safety profile amid international uncertainties and the continuous realization of catalysts for innovative drugs [2] - There are structural opportunities in the pharmaceutical sector, particularly with the integration of artificial intelligence in diagnostics and medical services, which may lead to sustained valuation improvements [1]
科创医药指数ETF(588700)涨超1.2%,微电生理涨超7%,机构:医药行情将迎来持续性修复